Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H17NO4 |
| Molecular Weight | 251.2784 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CC=C)=CC(C(=O)NCCO)=C1O
InChI
InChIKey=UMJHTFHIQDEGKB-UHFFFAOYSA-N
InChI=1S/C13H17NO4/c1-3-4-9-7-10(13(17)14-5-6-15)12(16)11(8-9)18-2/h3,7-8,15-16H,1,4-6H2,2H3,(H,14,17)
DescriptionCurator's Comment: The description was created based on several sources, including
https://www.drugs.com/international/alibendol.html | http://en.cnki.com.cn/Article_en/CJFDTOTAL-ABJB201206018.htm
Curator's Comment: The description was created based on several sources, including
https://www.drugs.com/international/alibendol.html | http://en.cnki.com.cn/Article_en/CJFDTOTAL-ABJB201206018.htm
Alibendol (2-hydroxy-N-(2-hydroxyethyl)-3-methoxy-5-prop-2-enyl benzamide) is an antispasmodic, choleretic, and cholekinetic compound, used in the treatment of gastrointestinal disorders in Egypt
Originator
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
5.82 μg/mL |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
ALIBENDOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
10.62 μg × h/mL |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
ALIBENDOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1.47 h |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
ALIBENDOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66913
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
247-960-9
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
3037
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
71916
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
SUB05323MIG
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
m1506
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | Merck Index | ||
|
A8CO1VZK2Z
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
117
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
26750-81-2
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
236219
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID4046490
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
C74231
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105999
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY | |||
|
100000087411
Created by
admin on Mon Mar 31 17:58:08 GMT 2025 , Edited by admin on Mon Mar 31 17:58:08 GMT 2025
|
PRIMARY |
ACTIVE MOIETY